Ola Myklebost
Universitetet i Bergen
H-index: 67
Europe-Norway
Top articles of Ola Myklebost
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Deciphering the role of FUS:: DDIT3 expression and tumor microenvironment in myxoid liposarcoma development | Journal of Translational Medicine | Parmida Ranji Emma Jonasson Lisa Andersson Stefan Filges Manuel Luna Santamaría | 2024/12 |
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma | Nature Communications | Yang Zhou Partho Sarothi Ray Jianguo Zhu Frank Stein Mandy Rettel | 2024/4/1 |
Evolutionary mode and timing of dissemination of high-grade serous carcinomas | JCI insight | Anita Sveen Bjarne Johannessen Solveig MK Klokkerud Sigrid M Kraggerud Leonardo A Meza-Zepeda | 2024/2/8 |
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing | Nature genetics | Isidro Cortés-Ciriano Jake June-Koo Lee Ruibin Xi Dhawal Jain Youngsook L Jung | 2023/6 |
Author Correction: Pan-cancer analysis of whole genomes | Nature | 2023/2/16 | |
Heritable defects in telomere and mitotic function selectively predispose to sarcomas | Science | Mandy L Ballinger Swetansu Pattnaik Piyushkumar A Mundra Milita Zaheed Emma Rath | 2023/1/20 |
Author Correction: The evolutionary history of 2,658 cancers (Nature,(2020), 578, 7793,(122-128), 10.1038/s41586-019-1907-7) | Nature | Moritz Gerstung Clemency Jolly Ignaty Leshchiner Stefan C Dentro Santiago Gonzalez | 2023/2/16 |
Chromosomal instability and a deregulated cell cycle are intrinsic features of high‐risk gastrointestinal stromal tumours with a metastatic potential | Molecular Oncology | Heidi Maria Namløs Ksenia Khelik Sigve Nakken Daniel Vodák Eivind Hovig | 2023/11 |
The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition | Frontiers in immunology | Irantzu Anzar Brandon Malone Pubudu Samarakoon Ioannis Vardaxis Boris Simovski | 2023/9/20 |
Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy | Genome Medicine | Andreas Venizelos Christina Engebrethsen Wei Deng Jürgen Geisler Stephanie Geisler | 2022/8/11 |
Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence | Leukemia | Kristine Misund Davine Hofste Op Bruinink Eivind Coward Remco M Hoogenboezem Even Holth Rustad | 2022/7 |
miR-486-5p expression is regulated by DNA methylation in osteosarcoma | BMC genomics | Heidi M Namløs Magne Skårn Deeqa Ahmed Iwona Grad Kim Andresen | 2022/2/17 |
Multi-Omics Profiling of Longitudinal Samples Reveals Early Genomic Changes in Follicular Lymphoma | Blood | Baoyan Bai Jillian F Wise Daniel Vodák Sigve Nakken Ankush Sharma | 2022/11/15 |
Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour | Pathology | Tatiana Georgiesh Heidi Maria Namløs Nitin Sharma Susanne Lorenz Ola Myklebost | 2021/10/1 |
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden | Nature communications | Peter Peneder Adrian M Stütz Didier Surdez Manuela Krumbholz Sabine Semper | 2021/5/28 |
Methylation-dependent SUMOylation of the architectural transcription factor HMGA2 | Biochemical and Biophysical Research Communications | Marianne Stabell Thomas Sæther Åsmund K Røhr Odd S Gabrielsen Ola Myklebost | 2021/5/7 |
Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening | Plos one | Iwona Grad Robert Hanes Pilar Ayuda-Durán Marieke Lydia Kuijjer Jorrit M Enserink | 2021/3/10 |
The expressed mutational landscape of microsatellite stable colorectal cancers | Genome Medicine | Anita Sveen Bjarne Johannessen Ina A Eilertsen Bård I Røsok Marie Gulla | 2021/12 |
Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high‐throughput germline screening in cancer | International Journal of Cancer | Sigve Nakken Vladislav Saveliev Oliver Hofmann Pål Møller Ola Myklebost | 2021/12/1 |
Accurate 3-gene-signature for early diagnosis of liposarcoma progression | Clinical Sarcoma Research | Anastassia Serguienko Peder Braadland Leonardo A Meza-Zepeda Bodil Bjerkehagen Ola Myklebost | 2020/12 |
